Asxl1 deficiency in embryonic fibroblasts leads to cellular senescence via impairment of the AKT-E2F pathway and Ezh2 inactivation
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Asxl1 deficiency in embryonic fibroblasts leads to cellular senescence via impairment of the AKT-E2F pathway and Ezh2 inactivation
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-07-06
DOI
10.1038/s41598-017-05564-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic significance ofASXL1mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: A meta-analysis
- (2016) Yun Lin et al. Hematology
- Role of Asxl1 in kidney podocyte development via its interaction with Wtip
- (2015) Seungtae Moon et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Loss of BAP1 function leads to EZH2-dependent transformation
- (2015) Lindsay M LaFave et al. NATURE MEDICINE
- Inactivation of AKT Induces Cellular Senescence in Uterine Leiomyoma
- (2014) Xiaofei Xu et al. ENDOCRINOLOGY
- EZH2: biology, disease and structure-based drug discovery
- (2013) Jin-zhi Tan et al. ACTA PHARMACOLOGICA SINICA
- Stressing the cell cycle in senescence and aging
- (2013) Hollie Chandler et al. CURRENT OPINION IN CELL BIOLOGY
- EZH2 in normal and malignant hematopoiesis
- (2013) K Lund et al. LEUKEMIA
- ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression
- (2012) Omar Abdel-Wahab et al. CANCER CELL
- Aberrations of EZH2 in Cancer
- (2011) A. Chase et al. CLINICAL CANCER RESEARCH
- De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome
- (2011) Alexander Hoischen et al. NATURE GENETICS
- Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence
- (2011) Lars-Gunnar Larsson SEMINARS IN CANCER BIOLOGY
- Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations
- (2010) W.-C. Chou et al. BLOOD
- p27: A Barometer of Signaling Deregulation and Potential Predictor of Response to Targeted Therapies
- (2010) S. A. Wander et al. CLINICAL CANCER RESEARCH
- Additional Sex Comb-like (ASXL) Proteins 1 and 2 Play Opposite Roles in Adipogenesis via Reciprocal Regulation of Peroxisome Proliferator-activated Receptor γ
- (2010) Ui-Hyun Park et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- 1,25-dihydroxyvitamin D3 and PI3K/AKT inhibitors synergistically inhibit growth and induce senescence in prostate cancer cells
- (2010) Linara S. Axanova et al. PROSTATE
- Polycomb protein Ezh2 regulates pancreatic -cell Ink4a/Arf expression and regeneration in diabetes mellitus
- (2009) H. Chen et al. GENES & DEVELOPMENT
- Protocols to detect senescence-associated beta-galactosidase (SA-βgal) activity, a biomarker of senescent cells in culture and in vivo
- (2009) Florence Debacq-Chainiaux et al. Nature Protocols
- CDKN1C (p57KIP2) Is a Direct Target of EZH2 and Suppressed by Multiple Epigenetic Mechanisms in Breast Cancer Cells
- (2009) Xiaojing Yang et al. PLoS One
- Protein Interaction Data Set Highlighted with Human Ras-MAPK/PI3K Signaling Pathways
- (2008) Jian Wang et al. JOURNAL OF PROTEOME RESEARCH
- p27Kip1 Inhibits Cyclin D-Cyclin-Dependent Kinase 4 by Two Independent Modes
- (2008) A. Ray et al. MOLECULAR AND CELLULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search